US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

38.27

+4.0611.87%

Post-market: 38.300.0300+0.08%19:59 EDT

Volume:368.31K

Turnover:13.85M

Market Cap:83.80M

PE:- -

High:39.75

Open:33.90

Low:33.88

Close:34.21

52wk High:391.58

52wk Low:12.38

Shares:2.19M

Float Shares:2.19M

Volume Ratio:1.03

T/O Rate:16.82%

Dividend:1.98

Dividend Rate:5.17%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says

THOMSON REUTERS

Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says

THOMSON REUTERS

Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Benzinga Earnings

Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth

Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss

MT Newswires Live

Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million

Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI

THOMSON REUTERS

Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers

THOMSON REUTERS

Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth

Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate

Benzinga Earnings

Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33

THOMSON REUTERS

Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million

Hims & Hers Health Q2 EPS USD -0.37

THOMSON REUTERS

Hims & Hers Health, Inc. Q3 REV View $793.1 Mln

THOMSON REUTERS

Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda

THOMSON REUTERS

Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year

THOMSON REUTERS

U.S. Earnings Preview: After Market Close Aug. 10

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/HIMZ/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":38.27,"timestamp":1787342400000,"preClose":34.21,"halted":0,"volume":368311,"hourTrading":{"tag":"盘后","latestPrice":38.3,"preClose":38.27,"latestTime":"19:59 EDT","volume":1948,"amount":74536.0122,"timestamp":1787356778318,"change":0.03,"changeRate":0.000784,"amplitude":0.006794},"delay":0,"changeRate":0.11867874890382936,"floatShares":2189606,"shares":2189606,"eps":0,"marketStatus":"Market Closed","change":4.06,"latestTime":"08-21 16:00:00 EDT","open":33.9,"high":39.75,"low":33.875,"amount":13852405.799441999,"amplitude":0.171733,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.21,"sharesOutstanding":57385000,"nav":34.36,"aum":74547696.52,"dividendRate":0.051738,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.01,"preClose":34.21,"latestTime":"09:29 EDT","volume":5080,"amount":176115.50756,"timestamp":1787318998897,"change":-0.2,"changeRate":-0.005846,"amplitude":0.028939},"postHourTrading":{"tag":"盘后","latestPrice":38.3,"preClose":38.27,"latestTime":"19:59 EDT","volume":1948,"amount":74536.0122,"timestamp":1787356778318,"change":0.03,"changeRate":0.000784,"amplitude":0.006794},"volumeRatio":1.0339690461197766,"impliedVol":1.5545,"impliedVolPercentile":0.3904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":2189606,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0339690461197766,"shares":2189606,"dividePrice":1.98,"high":39.75,"amplitude":0.171733,"preClose":34.21,"low":33.875,"week52Low":12.3816,"pbRate":"--","week52High":391.58,"institutionHeld":0,"latestPrice":38.27,"eps":0,"divideRate":0.051738,"volume":368311,"delay":0,"ttmEps":0,"open":33.9,"prevYearClose":81.06,"prevWeekClose":27.45,"prevMonthClose":27.69,"prevQuarterClose":48.7861,"fiveDayClose":27.45,"twentyDayClose":29.77,"sixtyDayClose":28.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658954585","title":"Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954585?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","GLAM","HEAL","HIYY","HIMS","HIMZ","THNR","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951208","title":"Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951208?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HEAL","BK4196","HIMY","HIMZ","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658519329","title":"Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658519329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658519329?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:31","pubTimestamp":1786393860,"startTime":"0","endTime":"0","summary":"Hims & Hers Health raised its revenue projections for the year, though higher costs swung it to a loss in the second quarter.The telehealth platform said it now projects $3.1 billion to $3.3 billion i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","GLAM","BK4196","HIMY","HIYY","THNR","HEAL","HIMS","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658285959","title":"Hims & Hers Shares Drop After Mixed Q2 Earnings — Details","url":"https://stock-news.laohu8.com/highlight/detail?id=2658285959","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658285959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:17","pubTimestamp":1786393043,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers posted Q2 results - here are the details you need to know.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61092738/hims-hers-shares-drop-after-mixed-q2-earnings-details","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMZ","HIYY","GLAM","HIMS","THNR","HIMY","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959179","title":"Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959179","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959179?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:15","pubTimestamp":1786392909,"startTime":"0","endTime":"0","summary":"Telehealth platform Hims & Hers swings to Q2 net loss as margin pressure offsets revenue growthOverviewUS health platform's Q2 revenue rose 38% yr/yr, beating analyst expectationsCompany posted Q2 net","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIMZ","HIMS","GLAM","BK4196","HEAL","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995931","title":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995931","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995931?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392570,"startTime":"0","endTime":"0","summary":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIYY","HIMY","THNR","BK4196","HMYY","HIMZ","HEAL","GLAM","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995959","title":"Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995959","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392559,"startTime":"0","endTime":"0","summary":"Hims & Hers Q2 FY26 net loss widens to $86.3 million; revenue rises 38% to $753.2 millionHims & Hers posted Q2 2026 revenue of USD 753.2 million, up 38% year-over-year; net results swung to a USD 86.3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL2PdtJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HMYY","HIYY","HIMZ","HIMS","THNR","HEAL","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959334","title":"Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959334?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMZ","HIMY","BK4196","GLAM","THNR","HEAL","HMYY","HIMS","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695934","title":"Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695934?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HIMZ","BK4196","HEAL","HMYY","THNR","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959350","title":"Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959350","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959350?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392494,"startTime":"0","endTime":"0","summary":"Hims & Hers posts higher quarterly revenue on strong subscriber growthNEW YORK, Aug 10 -Hims & Hers HealthHIMS.Non Monday posted a rise in second-quarter revenue as the telehealth company benefited from an increase in subscribers and expanding its personalized healthcare offerings.The company reported revenue of $753 million during the quarter, compared with $544 million a year ago. Analysts were expecting a revenue of $699.89 million, per data compiled by LSEG.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4471ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","BK4196","HEAL","GLAM","HIMZ","THNR","HIMS","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959874","title":"Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959874","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959874?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392452,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over earnings of $0.17 per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61091412/hims-hers-health-q2-eps-0-37-misses-0-03-estimate-sales-753-214m-beat-699-889m-estimate","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimat...","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMZ","HIYY","GLAM","HIMS","BK4196","THNR","HMYY","HEAL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658598159","title":"Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2658598159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658598159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL6N4470Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HIMS","HEAL","HMYY","GLAM","HIMZ","THNR","BK4196","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959895","title":"Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959895","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959895?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392361,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 MillionAug 10  - Hims & Hers Health Q2 net income USD -86.3 million.outlook FY revenue USD 3,100-3,300 million vs. IBES estimate USD 2,928 millionoutlook FY adjusted EBITDA USD 275-325 million vs. IBES estimate USD 296.2 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMZ","GLAM","BK4196","HIYY","HEAL","HIMS","HMYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959814","title":"Hims & Hers Health Q2 EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959814?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMZ","HIMY","HMYY","BK4196","HEAL","GLAM","HIMS","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959546","title":"Hims & Hers Health, Inc. Q3 REV View $793.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959546?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HMYY","HIYY","HIMZ","HIMS","THNR","HEAL","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956027","title":"Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956027?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HEAL","BK4196","HIMY","HIYY","HIMZ","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658051956","title":"Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658051956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658051956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIYY","HEAL","HIMY","HIMZ","HMYY","GLAM","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956339","title":"U.S. Earnings Preview: After Market Close Aug. 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956339","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956339?lang=en_us&edition=fundamental","pubTime":"2026-08-11 03:30","pubTimestamp":1786390200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the marke","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","ERET","IYRI","THNR","SPG","HIMY","BK4187","UPWK","OPFI","HMYY","BK4505","LU0124676726.USD","BK4166","BK4231","BK4130","RWO","LU2360107325.USD","FREL","BK4204","DFGR","XLRE","FRI","LU2190626999.HKD","RITA","ACVA","LU1499592464.USD","URE","BKD","BK4088","LU0689626769.HKD","USRT","VNQ","BZH","DPRE","LU1861214812.USD","BK4603","IE00B7SZL793.SGD","BK4196","RSPR","ARCX","LU0842063009.USD","IQRA","TRUR","GLAM","IYR","LU2298064838.USD","BK4585","AVRE","HPK","LU0187121727.USD","REET","BK4225","REIT","VGSR","BK4516","IE0031619046.USD","IE00B66KJ199.SGD","RNTY","ACHR","BBIO","APEI","HLIO","NHI","BK4129","LU1939255532.USD","ACM","BK4137","LU2308191902.HKD","HEAL","BK4203","BK4139","BK4213","IE00B19Z4B17.USD","SCHH","HIMZ","BK4080","RWR","BK4161","LU2244417387.USD","JRE","GQRE","BK4185","HIMS","BK4588","LU2238339852.HKD","CRED","BBRE","ICF","DFAR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939006","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939006?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:50","pubTimestamp":1786366208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","HIMS","HIMY","IBRN","THNR","HIMZ","BK4139","HMYY","HEAL","DNTH","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980780","title":"Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980780","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980780?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359487,"startTime":"0","endTime":"0","summary":"HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61068991/hims-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HEAL","BK4196","HIMY","HIMZ","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}